Nicoline Jochmann Felix Kiecker Adrian C Borges Maja A Hofmann Stephan Eddicks Wolfram Sterry Gert Baumann Uwe Trefzer
10.1186/1476-7120-3-26
Cardiovasc Ultrasound
2005 Sep 2;3:26.
CC BY
https://pubmed.ncbi.nlm.nih.gov/16138923/
Hypertension, Pulmonary / chemically induced Hypertension, Pulmonary / drug therapy Imidazoles / administration & dosage Interferon-alpha / adverse effects Phosphodiesterase Inhibitors / administration & dosage Piperazines / administration & dosage
Hypertension, Pulmonary / chemically induced Hypertension, Pulmonary / drug therapy Imidazoles / administration & dosage Interferon-alpha / adverse effects Phosphodiesterase Inhibitors / administration & dosage Piperazines / administration & dosage Case Reports 3',5'-Cyclic-GMP Phosphodiesterases Adult Cyclic Nucleotide Phosphodiesterases, Type 5 Female Humans Interferon-alpha / therapeutic use Melanoma / drug therapy Phosphoric Diester Hydrolases / drug effects Purines Sildenafil Citrate Sulfones / administration & dosage Time Factors Treatment Outcome Triazines / administration & dosage Vardenafil Dihydrochloride Imidazoles Interferon-alpha Phosphodiesterase Inhibitors Piperazines Purines Sulfones Triazines Vardenafil Dihydrochloride Sildenafil Citrate Phosphoric Diester Hydrolases 3',5'-Cyclic-GMP Phosphodiesterases Cyclic Nucleotide Phosphodiesterases, Type 5 PDE5A protein, human
PMC1208925
16138923
Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report
2005